APA (7th ed.) Citation

AL, C., I, C., DE, B., I, C. H., N, B., C, P., . . . A, S. (2022). Quantitative contrast-enhanced endoscopic ultrasound in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors: Can we predict survival using perfusion parameters? A pilot study. Medical ultrasonography, 24(4), 393. https://doi.org/10.11152/mu-3503

Chicago Style (17th ed.) Citation

AL, Constantin, et al. "Quantitative Contrast-enhanced Endoscopic Ultrasound in Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumors: Can We Predict Survival Using Perfusion Parameters? A Pilot Study." Medical Ultrasonography 24, no. 4 (2022): 393. https://doi.org/10.11152/mu-3503.

MLA (9th ed.) Citation

AL, Constantin, et al. "Quantitative Contrast-enhanced Endoscopic Ultrasound in Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumors: Can We Predict Survival Using Perfusion Parameters? A Pilot Study." Medical Ultrasonography, vol. 24, no. 4, 2022, p. 393, https://doi.org/10.11152/mu-3503.